• About Pharma Info Nepal 
  • Contact
  • Courses
  • Home
  • Instructors
  • Nabin Bista
  • Pharmacy Act and Guidelines
  • Pharmacy Books
  • Privacy Policy
  • Profile
  • Terms and Conditions
  • Terms Of Use
Saturday, May 24, 2025
Pharma Info Nepal
No Result
View All Result
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Questions

Nepal Pharmacy Council License Exam Pharmacology Questions BPharmacy

Nepal Pharmacy Council License Exam Pharmacology Questions BPharmacy

Nabin Bista by Nabin Bista
May 16, 2021
in Questions
0
Nepal Pharmacy Council License Exam Pharmacology Questions BPharmacy
7.3k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Nepal Pharmacy Council License Exam Pharmacology Questions BPharmacy

Nepal Pharmacy Council License Exam Pharmacology Questions for BPharmacy

1. Type B adverse drug reaction is ?
(a) Augmented effect of the drug
(b) Allergic effect of the drug
(c) Effect seen on chronic use of the drug
(d) Delayed effect of the drug

2. All of the following drugs can cause SLE like syndrome except ?
(a) Isoniazid
(b) Penicillin
(c) Hydralazine
(d) Sulphonamide

3. All of the following antiepileptics are microsomal enzyme inducers except
(a) Valproate
(b) Phenobarbitone
(c) Phenytoin
(d) Rifampicin

4. Which of the following drug is contraindicated in pregnancy?
(a) Enalapril
(b) Amlodipine
(c) ß-blockers
(d) Propylthiouracil

5. Two drugs having opposite action on different receptors is which type of antagonism?
(a) Physical antagonism
(b) Competitive antagonism
(c) Non competitive antagonism
(d) Physiological antagonism

6. Increase in cAMP is caused by:
(a) Somatostatin
(b) ß (Beta) receptor
(c) a (Alpha) receptor
(d) Acetylcholine

7. Apparent volume of distribution (aVd) is more than total body fluid if drug is:
(a) Poorly soluble
(b) Sequestered in tissues
(c) Slow elimination
(d) Poorly plasma protein bound

8. Most essential medicines should be formulated as:
(a) No compound
(b) Single compound
(c) Multiple compounds
(d) Fixed dose combinations

9. Drug which does not cause hemolysis in G6PD deficiency is?
(a) Primaquine
(b) Dapsone
(c) Corticosteroids
(d) Methylene Blue

10. Phase 4 clinical trial also called as?
(a) Human pharmacology and safety
(b) Post marketing surveillance
(c) Therapeutic exploration and dose ranging
(d) Therapeutic confirmation

11. Which of the following is an effect of grapefruit juice on drug metabolism?
(a) Enzyme inducer
(b) Enzyme inhibitor
(c) Inhibits tubular secretion
(d) Inhibits tubular reabsorption

12. Which of the following is an example of physiological antagonism?
(a) Heparin-Protamine
(b) Prostacycline-Thromboxane
(c) Adrenaline-Phenoxybenzamine
(d) Physostigmine-Acetylcholine

13. Which is not an alkaloid?
(a) Morphine
(b) Neostigmine
(c) Emetine
(d) Atropine

14. Therapeutic index is a measure of:
(a) Efficacy
(b) Adverse effects
(c) Safety
(d) Potency

15. Which of the following doesnot included in Pharmacokinetic Parameter:
(a) Absorption
(b) Distribution
(c) Biotransformation
(d) Drug Action

16. All the following drugs are teratogenic except:
(a) Alcohol
(b) Phenytoin
(c) Warfarin
(d) Metoclopramide

17. All the following drugs act on ionic channels except:
(a) Nicotine
(b) Insulin
(c) Glibenclamide
(d) Diazepam

18. Efficacy of a drug refers to:
(a) Affinity of drug to bind to receptors
(b) Affinity of drug that binds to receptors and activates it
(c) Dose that requires to produce response
(d) Maximum response a drug can produce

19. Phocomelia is best described as:
(a) Defect in development of long bones
(b) Defect in development of flat bones
(c) Defect in intramembranous ossification
(d) Defect in cartilge replacement by bones

20. Phase IV of clinical trials collect information specially about:
(a) Drug efficacy
(b) Drug potency
(c) Drug toxicity
(d) Pharmacokinetics of the drug

21. SLE like reaction is caused by:
(a) Hydralazine
(b) Rifampicin
(c) Paracetamol
(d) Furosemide

22. Which of the following can result in oral contraceptive failure?
(a) Valproate
(b) Rifampicin
(c) NSAIDs
(d) Ethambutol

23. When a drug binds to the receptor and causes action opposite to that of agonist this is called as?
(a) Complete Agonist
(b) Partial Agonist
(c) Inverse agonist
(d) Neutral antagonist

24. The study of how variation in the human genome affect the response to medications is known as?
(a) Pharmacogenomics
(b) Pharmacokinetics
(c) Pharmacotherapeutics
(d) Pharmacovigilance

25. Zero order kinetics occur in following drug with high dose:
(a) Phenytoin and propranolol
(b) Digoxin and propranolol
(c) Amiloride and prebenecid
(d) Alcohol and theophylline

26. Which of the following is the most accurate method for calculating drug dosage in children:
(a) Weight of the child
(b) Weight of the child and adult dose
(c) Age of the child
(d) Body surface area

27. Therapeutic drug monitoring is done for all the following except:
(a) Phenytoin
(b) Metformin
(c) Tacrolimus
(d) Cyclosporin

28. The drug which may inhibit P450 for warfarin is which one of the following:
(a) Cimetidine
(b) Ethanol
(c) Rifampicin
(d) Procainamide

29. In which type of poisonings is gastric lavage contraindicated?
(a) organophosphorus poisoning
(b) Sedative drug poisoning
(c) Corrosive acid poisoning
(d) Barium carbonate poisoning

30. All of the following are examples of time dependent late adverse drug reactions except:
(a) Glucocorticoid induced osteoporosis
(b) Nitrate induced headache
(c) Chloroquine induced retinopathy
(d) Amiodarone induced tissue phospholipid deposition

31. Phase 4 clinical trial is carried out:
(a) Before the marketing approval of a drug
(b) After a drug is marketed
(c) For drugs used in rare diseases
(d) For drugs used in pediatric patients

32. Forced alkaline diuresis is effective in management of poisoning by which of the following agents:
(a) Phenobarbitone
(b) Lead
(c) Iron
(d) organophosphates

33. Which of the following drugs can be given safety in pregnancy:
(a) Propylthiouracil
(b) Sodium valproate
(c) Warfarin
(d) Tetracycline

34. Which ONE of the following is TRUE about a competitive antagonism?
(a) Antagonism cannot be completely reversed by increased dose of the agonist
(b) An agonist cannot displace an antagonists from the receptor
(c) Agonists and antagonists bind to the same receptor
(d) Dose-response curve of an agonists shifts to the left in the presence of an antagonist

35. Which route of drug administration avoids first pass hepatic metabolism and is used with drug preparation that slowly releases drugs for periods as long as seven days?
(a) Topical
(b) Transdermal
(c) Sublingual
(d) oral

36. Essential medicines are those medicines:
(a) That are needed to treat emergency conditions
(b) That are needed to treat serious diseases
(c) That satisfy the priority health care needs of the population
(d) That are introduced recently into the market

37. A drug that compete for active binding site is called:
(a) Competitive inhibitor
(b) Non-competitive inhibitor
(c) Covalent inhibitor
(d) Any of these

38. Usually healthy human volunteers are taken in:
(a) Phase I of clinical trial
(b) Phase II of clinical trial
(c) Phase III of clinical trial
(d) Phase IV of clinical trial

39. Orphan drugs are:
(a) Drugs with high therapeutic failure
(b) Drugs with high toxicity
(c) Drugs having low therapeutic margin
(d) Drugs for rare disease

40. Hemodialysis is useful in all of the following except:
(a) Barbiturate poisoning
(b) Methanol poisoning
(c) Salicylate poisoning
(d) Digoxin poisoning

41. Elimination after 3 half lives in first order kinetics
(a) 12.5%
(b) 75%
(c) 87.5%
(d) 94%

42. Drug remaining in the body after 3 half lives is:
(a) 12.5%
(b) 75%
(c) 87.5%
(d) 94%

43. The bioavailability of the drug depends upon:
(a) First pass metabolism
(b) Second pass metabolism
(c) Volume of distribution
(d) Excretion

44. Bioavailability is:
(a) Amount of drug that reach the systemic circulation
(b) Drug metabolized in liver before the drug reaches the systemic circulation
(c) Drug metabolized in liver after the drug reaches the systemic circulation
(d) Maximum by rectal route

45. Therapeutic index is a measure of:
(a) Drug safety
(b) Bioavailability
(c) Potency
(d) Efficacy

46. Partial agonist possess
(a) Max. intrinsic activity and low affinity
(b) High intrinsic activity and no affinity
(c) Low intrinsic activity and high affinity
(d) Low intrinsic activity and low affinity

47. About biotransformation untrue is:
(a) Inactive metabolites are formed
(b) Active metabolites are formed
(c) More fat soluble metabolites are formed
(d) More H2O soluble metabolites are formed

48. Which of the following is not a pro-drug?
(a) Levodopa
(b) Enalapril
(c) Dipivefrine
(d) Amoxicillin

49. Which of the following is a prodrug?
(a) Lisinopril
(b) Enalapril
(c) Chlorpromazine
(d) Dopamine

50. Pharmacodynamics includes:
(a) Drug elimination
(b) Drug excretion
(c) Drug absorption
(d) Mechanism of action

 

Answers

1. b 2. b 3. a 4. a 5.d
6. b 7. b 8. b  9. c 10. b 
11. b 12. b  13. b  14. c  15. d
16. d  17. b 18. d 19. a  20. c
21. a 22. b 23. c 24. a 25. d
26.d  27. b 28. a 29. a 30. b 
31. b 32. a 33. a 34. c 35. b
36. c 37. a 38. a 39. d 40. d
41. c 42. a 43. a 44. a 45. a
46.c  47. c  48. d 49. b  50. d


More Questions for Practice:

  • Pharmaceutics MCQs for Pharmacy Exams 
  • MCQs of Pharmacology
  • Pharmacology Online Exam – I 
  • Pharmacology Model Question Set – II
  • Pharmacy Loksewa Questions 2075
  • Pharmacy Loksewa Questions
  • 50 Pharmacognosy Important Questions for Pharmacy License and Loksewa Exam
  • Pharmacology Questions for License and Loksewa Exam
  • Pharmaceutical Calculation MCQs for Pharmacy Students 
  • Pharmacology MCQs Antipsychotic Drugs 
  • Pharmaceutics Important MCQs for Pharmacy License and Loksewa 
  • Nepal Pharmacy Council License Exam Model set For Pharmacy Assistant
  • Nepal Pharmacy Council License Exam Past Question Collection


Related Syllabus:

  • Pharmacy Supervisor Loksewa Syllabus
  • Pharmacy Officer Loksewa Syllabus
  • Pharmacist License Exam Syllabus Nepal Pharmacy Council
  • Nepal Pharmacy Council License Exam Syllabus Diploma Pharmacy 
Tags: Questions
Previous Post

DDA Notice for the Production, Import and Sale of Sanitizers in Nepal

Next Post

Vacancy Announcement Infectious and Communicable Diseases Hospital Pokhara

Nabin Bista

Nabin Bista

Hello, Thank You for visiting my blog I am Nabin Bista, Dedicated and self motivated young Registered Pharmacist from Nepal. Blogging is my passion. I did my B Pharmacy from Institute of Medicine - IOM, Currently working as Hospital Pharmacist at Patan Academy of Health Sciences (PAHS). If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

Related Posts

Pharmaceutical Calculations MCQs – 30 Questions with Answers
B Pharmacy

Pharmaceutical Calculations MCQs – 30 Questions with Answers

May 22, 2025
Clinical Pharmacy MCQs for Nepal Pharmacy Council License Exam and Loksewa
License

Clinical Pharmacy MCQs for Nepal Pharmacy Council License Exam and Loksewa

April 14, 2025
Nepal Pharmacy Council License Exam Past Questions
License

Nepal Pharmacy Council License Exam Past Questions

April 6, 2025
Nepal Nursing Council License Exam Questions
Questions

Nepal Nursing Council License Exam Questions

April 5, 2025
Nepal Pharmacy Council License Exam MCQs
License

Nepal Pharmacy Council License Exam MCQs

April 1, 2025
MCQs on Community Pharmacy for NPC License & Loksewa Exam
License

MCQs on Community Pharmacy for NPC License & Loksewa Exam

March 25, 2025
Load More
Next Post
Vacancy Announcement Infectious and Communicable Diseases Hospital Pokhara

Vacancy Announcement Infectious and Communicable Diseases Hospital Pokhara

Discussion about this post

Recommended

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

Vacancy Announcement for Pharmacy Lecturer Medicinal Chemistry and Pharmaceutical Analysis

May 24, 2025
Pharmaceutical Calculations MCQs – 30 Questions with Answers

Pharmaceutical Calculations MCQs – 30 Questions with Answers

May 22, 2025
Vacancy Announcement at Simca Laboratories Pvt. Ltd

Vacancy Announcement at Simca Laboratories Pvt. Ltd

May 22, 2025
Best NPC License Preparation Classes in Nepal for Pharmacy Students

Best NPC License Preparation Classes in Nepal for Pharmacy Students

May 22, 2025
WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

WHO-GMP Certified Domestic Drug Manufacturers in Nepal: Current Status and Future Outlook

May 21, 2025
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

Important Information

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

Categories

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy

DOWNLOADS

Pharmacy Book 

Pharmacy Act and Guidelines

About Pharma Info Nepal

About Admin

  • About Pharma Info Nepal 
  • Contact
  • Courses
  • Home
  • Instructors
  • Nabin Bista
  • Pharmacy Act and Guidelines
  • Pharmacy Books
  • Privacy Policy
  • Profile
  • Terms and Conditions
  • Terms Of Use

© 2025 Pharma Info Nepal | All Rights Reserved

error:
No Result
View All Result

© 2025 Pharma Info Nepal | All Rights Reserved